Report overview
This report contains market size and forecasts of Cell Line Development Equipment in global, including the following market information:
Global Cell Line Development Equipment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell Line Development Equipment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cell Line Development Equipment companies in 2021 (%)
The global Cell Line Development Equipment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Incubators Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Line Development Equipment include American Type Culture Collection (ATCC) (US), Lonza Group AG (Switzerland), Thermo Fisher Scientific, Inc. (US), GE Healthcare (U.K.), Sigma-Aldrich Corporation (US), Selexis SA (Switzerland), European Collection of Cell Cultures (ECACC) (U.K.), Corning, Inc. (US) and WuXi AppTec, Inc. (China) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Line Development Equipment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Line Development Equipment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Line Development Equipment Market Segment Percentages, by Type, 2021 (%)
Incubators
Centrifuges
Bioreactors
Storage Equipment
Automated Systems
Microscopes
Filtration Systems
Others
Global Cell Line Development Equipment Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Line Development Equipment Market Segment Percentages, by Application, 2021 (%)
Bioproduction
Tissue Engineering & Regenerative Medicines
Toxicity Testing
Research
Drug Discovery
Others
Global Cell Line Development Equipment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Line Development Equipment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Line Development Equipment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell Line Development Equipment revenues share in global market, 2021 (%)
Key companies Cell Line Development Equipment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cell Line Development Equipment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
American Type Culture Collection (ATCC) (US)
Lonza Group AG (Switzerland)
Thermo Fisher Scientific, Inc. (US)
GE Healthcare (U.K.)
Sigma-Aldrich Corporation (US)
Selexis SA (Switzerland)
European Collection of Cell Cultures (ECACC) (U.K.)
Corning, Inc. (US)
WuXi AppTec, Inc. (China)
Sartorious AG (Germany)
